An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering products of unknown origin.
Several professionals stated the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Response and Material Removal
Based on the social media company, the platform has taken down violative content and prohibited related keywords and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.
Online Trading Activities
Investigations also discovered groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.
After moments of joining one community, a vendor shared contact information, where most transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, posts show dark colored parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram stated it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.
